InMode

$72.18
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$3.22 (+4.67%) As of 4:10 PM UTC today

Why Robinhood?

You can buy or sell InMode and other stocks, options, and ETFs commission-free!

About INMD

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel. The listed name for INMD is InMode Ltd. Ordinary Shares.

CEO
Moshe Mizrahy
Employees
311
Headquarters
Yokneam, Tel Aviv
Founded
2008
Market Cap
2.88B
Price-Earnings Ratio
33.14
Dividend Yield
—
Average Volume
1.06M
High Today
$72.88
Low Today
$69.65
Open Price
$70.00
Volume
783.16K
52 Week High
$73.00
52 Week Low
$13.14

INMD Earnings

-$0.06
$0.27
$0.61
$0.94
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 5, Pre-Market

You May Also Like

PCG-E
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure